The Next Era of Diagnostic Stewardship
As molecular diagnostics expand what laboratories can detect, laboratories are placing greater emphasis on matching the breadth of testing to the patient and how the results will be used.
As molecular diagnostics expand what laboratories can detect, laboratories are placing greater emphasis on matching the breadth of testing to the patient and how the results will be used.
Visby Medical and Watchmaker Genomics have partnered to develop at-home PCR respiratory tests designed to overcome molecular inhibitors found in unprocessed clinical samples, according to a joint announcement.
Sample-to-answer assay delivers results in approximately 45 minutes from nasopharyngeal and nasal swab specimens.
A blood test predicts the likelihood of adults developing severe respiratory diseases by analyzing proteins linked to lung function decline.
Read MoreSaliva tests more accurately indicate the severity of recurrent respiratory infections in children compared to standard blood tests.
Read MoreResearchers developed a smartphone-controlled centrifugal microfluidic device that rapidly detects different subtypes of the influenza virus.
Read MoreResearchers developed a paper strip test using CRISPR technology that can quickly and accurately diagnose various influenza strains.
Read MoreRoche’s cobas liat COVID, Influenza A/B & RSV test, is a rapid RT-PCR assay that detects multiple respiratory viruses from a single sample.
Read MoreResearchers have developed an advanced electrostatic air sampler that enhances rapid detection of airborne influenza and coronavirus.
Read MoreQIAGEN’s QIAstat-Dx Respiratory Panel Plus, a syndromic testing tool for diagnosing respiratory infections, received FDA clearance.
Read MoreADLM’s new guidance on clinical testing for respiratory viral infections emphasizes the use of advanced diagnostic methods and sample types.
Read MoreResearchers demonstrated that metal-enhanced fluorescence probes could rapidly detect influenza virus proteins without complex lab equipment.
Read MoreEvidation has been awarded a contract by BARDA to fund the 2023 Influenza-like Illness (ILI) Detect & Protect Studies.
Read MoreA parallel test developed by Karius aims to improve treatment for serious diseases by diagnosing infections more rapidly and effectively.
Read MoreThe new biochip offers the potential to test multiple pathogens responsible for respiratory infections, such as COVID, RSV, and influenza.
Read MoreNew data provides a unique snapshot of the interplay among SARS-CoV-2, influenza, and respiratory syncytial virus (RSV).
Read MoreSAS and the Texas DSHS are teaming up on new public health dashboards powered by SAS Viya for tracking influenza data across the state.
Read MoreSekisui Diagnostics’ OSOM Ultra Plus Flu A&B Test is a rapid antigen test that takes only 10 minutes at the point of care.
Read More